Predictors of pacemaker dependency in patients implanted with a pacemaker after Transaortic valve replacement.

AS, Aortic Stenosis AV, atrioventricular LBBB, left bundle branch block LVEF, Left Ventricular Ejection Fraction PM, Pacemaker Pacemaker dependency Post-TAVR AV block Post-TAVR LBBB RBBB, right bundle branch block Sapiens TAVR TAVR, transaortic valve replacement Transcatheter aortic valve replacement

Journal

International journal of cardiology. Heart & vasculature
ISSN: 2352-9067
Titre abrégé: Int J Cardiol Heart Vasc
Pays: Ireland
ID NLM: 101649525

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 28 07 2020
revised: 12 09 2020
accepted: 30 09 2020
entrez: 16 11 2020
pubmed: 17 11 2020
medline: 17 11 2020
Statut: epublish

Résumé

The development of complete AV block and the need for pacemaker implantation (PM) is the most frequent complication after Transaortic valve replacement (TAVR). In other PM clinical contexts, a higher percentage of ventricular stimulation has been associated with worse prognosis. The objective was to study the existence of predictors of PM dependence. We identified 96 consecutive patients who had received a PM post-TAVR (all Core-Valve). We retrospectively analyzed this cohort with the aim of identifying predictors of a high and very high percentage of ventricular pacing (VP), PM dependency and survival. The mean age was 82.3 years, with a mean logistic EuroSCORE of 17.1, 53% were women and 12% of patients had LVEF < 50%. The indication was complete AV block in 40.5%, and LBBB in 59.5%. Mean survival was 62.7 months, IQR [54.4-71]. The only independent predictor of mortality was the pre-TAVR logistic Euro-SCORE (RR = 1,026, p = 0.033), but not LVEF < 50%, VP > 50%, VP > 85% or PM dependence. In 73 patients PM rhythm was documented at the end of follow-up. Of these, 14 (19.2%) were considered dependent, and 37 (50.7%) presented VP > 50%. The post-TAVR complete AV block recovery rate was 67.8%. In multivariate analysis, female sex (HR = 5.6, p = 0.005), and indication of complete AV block vs. LBBB (HR = 15.7, p = 0.017) were independently associated with PM dependency. Female sex and indication due to complete AV block were independent predictors of PM dependency during follow up. In our series of patients with mostly normal LVEF, a high percentage of stimulation does not influence prognosis.

Identifiants

pubmed: 33195792
doi: 10.1016/j.ijcha.2020.100654
pii: S2352-9067(20)30352-3
pmc: PMC7642861
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100654

Informations de copyright

© 2020 The Authors.

Références

Expert Rev Cardiovasc Ther. 2011 Jul;9(7):877-86
pubmed: 21809969
Circulation. 2012 Aug 7;126(6):720-8
pubmed: 22791865
N Engl J Med. 2010 Oct 21;363(17):1597-607
pubmed: 20961243
JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):70-3
pubmed: 25616820
J Am Coll Cardiol. 2010 Mar 16;55(11):1080-90
pubmed: 20096533
Circulation. 2017 Sep 12;136(11):1049-1069
pubmed: 28893961
Heart Rhythm. 2015 Aug;12(8):1717-25
pubmed: 25869753
JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt A):1139-1147
pubmed: 28412434
Circ Arrhythm Electrophysiol. 2014 Oct;7(5):968-77
pubmed: 25336367
Europace. 2018 Oct 1;20(10):1708
pubmed: 29518191
Int J Cardiol. 2013 Sep 30;168(2):1269-73
pubmed: 23295037
EuroIntervention. 2010 Sep;6(4):475-84
pubmed: 20884435
Int J Cardiol. 2017 Jun 1;236:216-220
pubmed: 28237734
JACC Cardiovasc Interv. 2018 Feb 12;11(3):301-310
pubmed: 29413244
Lancet. 1997 Oct 25;350(9086):1210-6
pubmed: 9652562
JAMA. 2002 Dec 25;288(24):3115-23
pubmed: 12495391
JACC Cardiovasc Interv. 2018 Aug 13;11(15):1495-1505
pubmed: 30031719
Am J Cardiol. 1997 Nov 15;80(10):1309-13
pubmed: 9388104
Am J Cardiol. 2001 Mar 1;87(5):649-51, A10
pubmed: 11230857
Eur Heart J. 2014 Oct 7;35(38):2639-54
pubmed: 25062953
J Am Coll Cardiol. 2013 Jan 22;61(3):e6-75
pubmed: 23265327
Heart. 2015 Oct;101(20):1665-71
pubmed: 26261157
Pacing Clin Electrophysiol. 2016 Jul;39(7):690-5
pubmed: 27073123
J Cardiovasc Electrophysiol. 2017 Feb;28(2):216-223
pubmed: 27943488
J Invasive Cardiol. 2014 Feb;26(2):94-9
pubmed: 24486670
J Cardiovasc Electrophysiol. 2005 Apr;16(4):359-65
pubmed: 15828875
N Engl J Med. 2009 Nov 26;361(22):2123-34
pubmed: 19915220
Am J Cardiol. 2013 Aug 15;112(4):554-9
pubmed: 23726173
J Am Coll Cardiol. 1992 Jun;19(7):1542-9
pubmed: 1593051
Cardiovasc Revasc Med. 2017 Jul - Aug;18(5S1):S10-S13
pubmed: 28377313
N Engl J Med. 2007 Sep 6;357(10):1000-8
pubmed: 17804844
Europace. 2017 Feb 1;19(2):282-288
pubmed: 28175255
J Cardiovasc Electrophysiol. 2008 Nov;19(11):1160-6
pubmed: 18554201
JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):60-9
pubmed: 25616819
Europace. 2012 Oct;14(10):1475-82
pubmed: 22447958
Circulation. 2003 Jun 17;107(23):2932-7
pubmed: 12782566
J Am Coll Cardiol. 2014 Jul 15;64(2):129-40
pubmed: 25011716
JACC Cardiovasc Interv. 2015 Apr 27;8(5):645-53
pubmed: 25946435

Auteurs

Pablo M Ruiz-Hernandez (PM)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Esteban Gonzalez-Torrecilla (E)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Enrique Gutierrez-Ibañez (E)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Hugo Gonzalez-Saldivar (H)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Vanesa Bruña (V)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Gerard Loughlin (G)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Evaristo Castellanos (E)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Pablo Avila (P)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Felipe Atienza (F)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Tomas Datino (T)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Jaime Elizaga (J)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Angel Arenal (A)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Francisco Fernández-Aviles (F)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Classifications MeSH